Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients
Covid19
About this trial
This is an interventional treatment trial for Covid19 focused on measuring Ivermectin, Doxycycline, COVID-19, Coronavirus, SARS-CoV-2
Eligibility Criteria
Inclusion Criteria:
- COVID-19 patients at any stage of this disease
Exclusion Criteria:
- Patients of allergic history to Ivermectin or to doxycyline
Sites / Locations
- Akarkh Healt hdirectorate
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Ivermectin-Doxycycline
Control
Ivermectin 200ug/kg PO per day for two days, and in some patients who needed more time to recover, a third dose 200ug/kg PO per day was given 7 days after the first dose. Doxycycline 100mg capsule PO every 12h per day was given for 5-10 days, based on the clinical improvement of patients. In addition, standard of care was given to the patients of Ivermectin-Doxycycline group based on the clinical condition of each patient.
Control group: The patients in this group received only standard care which included all or some of the following, according to the clinical condition of each patient.